Merck to Buy Harpoon Therapeutics for $680 Million

Merck has struck a deal to buy clinical-stage immunotherapy company Harpoon Therapeutics for about $680 million.

Related Keywords

Christopher Occhicone Bloomberg ,Merck Co ,Harpoon Therapeutics ,South San Francisco ,Biotechnology Services ,Pharmaceuticals ,Healthcare Life Sciences ,Biopharmaceuticals ,Biological Therapy ,Healthcare Provision ,Ownership Changes ,Acquisitions Mergers Shareholdings ,Acquisitions Mergers ,Corporate Actions ,Corporate Industrial News ,Content Types ,Factiva Filters ,C Ampe Industry News Filter ,Synd ,Wsj Pro Com ,Merck ,Mrk ,Sharp ,Acquisitions ,Mergers ,Shareholdings ,Corporate ,Industrial News ,Healthcare ,Life Sciences ,